Literature DB >> 30731090

Solution Conformation of Bovine Leukemia Virus Gag Suggests an Elongated Structure.

Dominic F Qualley1, Sarah E Cooper2, James L Ross2, Erik D Olson3, William A Cantara3, Karin Musier-Forsyth3.   

Abstract

Bovine leukemia virus (BLV) is a deltaretrovirus that infects domestic cattle. The structural protein Gag, found in all retroviruses, is a polyprotein comprising three major functional domains: matrix (MA), capsid (CA), and nucleocapsid (NC). Previous studies have shown that both mature BLV MA and NC are able to bind to nucleic acids; however, the viral assembly process and packaging of viral genomic RNA requires full-length Gag to produce infectious particles. Compared to lentiviruses, little is known about the structure of the Gag polyprotein of deltaretroviruses. In this work, structural models of full-length BLV Gag and Gag lacking the MA domain were generated based on previous structural data of individual domains, homology modeling, and flexible fitting to SAXS data using molecular dynamics. The models were used in molecular dynamic simulations to determine the relative mobility of the protein backbone. Functional annealing assays revealed the role of MA in the nucleic acid chaperone activity of BLV Gag. Our results show that full-length BLV Gag has an elongated rod-shaped structure that is relatively rigid, with the exception of the linker between the MA and CA domains. Deletion of the MA domain maintains the elongated structure but alters the rate of BLV Gag-facilitated annealing of two complementary nucleic acids. These data are consistent with a role for the MA domain of retroviral Gag proteins in modulating nucleic acid binding and chaperone activity. IMPORTANCE: BLV is a retrovirus that is found worldwide in domestic cattle. Since BLV infection has serious implications for agriculture, and given its similarities to human retroviruses such as HTLV-1, the development of an effective treatment would have numerous benefits. The Gag polyprotein exists in all retroviruses and is a key player in viral assembly. However, the full-length structure of Gag from any virus has yet to be elucidated at high resolution. This study provides structural data for BLV Gag and could be a starting point for modeling Gag-small molecule interactions with the ultimate goal of developing of a new class of pharmaceuticals.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Gag; matrix; molecular dynamics; retrovirus; small-angle X-ray scattering; viral assembly

Mesh:

Substances:

Year:  2019        PMID: 30731090      PMCID: PMC6424597          DOI: 10.1016/j.jmb.2019.01.036

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  87 in total

1.  The human immunodeficiency virus type 1 Gag polyprotein has nucleic acid chaperone activity: possible role in dimerization of genomic RNA and placement of tRNA on the primer binding site.

Authors:  Y X Feng; S Campbell; D Harvin; B Ehresmann; C Ehresmann; A Rein
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Multi-resolution contour-based fitting of macromolecular structures.

Authors:  Pablo Chacón; Willy Wriggers
Journal:  J Mol Biol       Date:  2002-03-29       Impact factor: 5.469

3.  The M-PMV cytoplasmic targeting-retention signal directs nascent Gag polypeptides to a pericentriolar region of the cell.

Authors:  Jeffrey N Sfakianos; Rachel A LaCasse; Eric Hunter
Journal:  Traffic       Date:  2003-10       Impact factor: 6.215

4.  A HIV-1 minimal gag protein is superior to nucleocapsid at in vitro annealing and exhibits multimerization-induced inhibition of reverse transcription.

Authors:  Ariel Roldan; Otis U Warren; Rodney S Russell; Chen Liang; Mark A Wainberg
Journal:  J Biol Chem       Date:  2005-02-24       Impact factor: 5.157

5.  Scalable molecular dynamics with NAMD.

Authors:  James C Phillips; Rosemary Braun; Wei Wang; James Gumbart; Emad Tajkhorshid; Elizabeth Villa; Christophe Chipot; Robert D Skeel; Laxmikant Kalé; Klaus Schulten
Journal:  J Comput Chem       Date:  2005-12       Impact factor: 3.376

Review 6.  Genetic determinants of bovine leukemia virus pathogenesis.

Authors:  L Willems; A Burny; D Collete; O Dangoisse; F Dequiedt; J S Gatot; P Kerkhofs; L Lefèbvre; C Merezak; T Peremans; D Portetelle; J C Twizere; R Kettmann
Journal:  AIDS Res Hum Retroviruses       Date:  2000-11-01       Impact factor: 2.205

7.  Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly.

Authors:  Jamil S Saad; Jaime Miller; Janet Tai; Andrew Kim; Ruba H Ghanam; Michael F Summers
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-13       Impact factor: 11.205

8.  Involvement of the matrix and nucleocapsid domains of the bovine leukemia virus Gag polyprotein precursor in viral RNA packaging.

Authors:  Huating Wang; Kendra M Norris; Louis M Mansky
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

9.  Bovine leukemia virus matrix-associated protein MA(p15): further processing and formation of a specific complex with the dimer of the 5'-terminal genomic RNA fragment.

Authors:  I Katoh; H Kyushiki; Y Sakamoto; Y Ikawa; Y Yoshinaka
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

10.  Association between bovine-leukosis virus seroprevalence and herd-level productivity on US dairy farms.

Authors:  S L Ott; R Johnson; S J Wells
Journal:  Prev Vet Med       Date:  2003-12-12       Impact factor: 2.670

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.